Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;77(6):679-695.
doi: 10.1007/s40265-017-0715-3.

Pediatric Osteoporosis: Diagnosis and Treatment Considerations

Edoardo Marrani  1 , Teresa Giani  1 , Gabriele Simonini  1 , Rolando Cimaz  2
Affiliations
Review

Pediatric Osteoporosis: Diagnosis and Treatment Considerations

Edoardo Marrani et al. Drugs. 2017 Apr.

Abstract

Osteoporosis is now increasingly recognized in children due to the increased prevalence of disorders associated with bone loss. Fragility fractures represent the cardinal clinical features of pediatric osteoporosis and children presenting with fragility fractures deserve an accurate assessment to rule out a secondary cause. Indeed, in the pediatric population, a low bone mass is often a consequence of a chronic disease or its treatment; genetic bone disorders represent the cause of only a small fraction of cases. The position statement of the International Society for Clinical Densitometry guides physicians in interpreting densitometric data and making diagnoses of osteoporosis in children. Once a diagnosis of osteoporosis has been made, the aim is to identify children in whom bone status may deteriorate if left untreated. To date, bisphosphonates have represented the mainstay of treatment for pediatric osteoporosis. However, due to the peculiar pathophysiology of osteoporosis in this age group, a pharmacological agent with an anabolic effect on bone may provide clinicians with other therapeutic options in children. Multicenter studies are needed to optimize treatments and define optimal clinical response in treated children.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Horm Res Paediatr. 2012;77(2):115-20 - PubMed
    1. Osteoporos Int. 2014 Oct;25(10):2359-81 - PubMed
    1. Bone. 2004 Nov;35(5):1038-45 - PubMed
    1. Environ Toxicol Pharmacol. 2016 Mar;42:212-7 - PubMed
    1. Bone. 2011 Jul;49(1):50-5 - PubMed

Substances

LinkOut - more resources